Menu
Το καλάθι σας

Lung Cancer Therapy Annual 7

Lung Cancer Therapy Annual 7
Lung Cancer Therapy Annual 7
  • Συγγραφείς: Rolf A. Stahel
  • ISBN: 9781841848655
  • Εκδότης: INFORMA
  • Έτος Έκδοσης: 2012
68,68€
Χωρίς ΦΠΑ: 64,79€

Oncology research and practice in lung cancer continues to develop rapidly. This latest edition of Lung Cancer Therapy Annual briefs the oncology community with a review of the recent literature, emphasizing the therapeutic aspects.

It offers an update of the impact that this information will have on the day-to-day management of the lung cancer patient.

New to the Seventh Edition:

 

  • An update of the impact of recent developments will have on day-to-day management of lung cancer patients
  • Four new chapters on the treatment of non-small cell lung cancer (NSCLC)
  • A new chapter on thymoma

 

Additional topics include:

 

  • Oncogenic driver mutations
  • First line therapy of advanced non-small cell lung cancer without activating EGFR mutation
  • Second line therapy of non-small cell lung cancer
  • Adjunct and neoadjunct therapy of non-small cell lung cancer
  • Advances in surgery of lung cancer; advances in radiotherapy of lung cancer
  • Mesothelioma
  • Thymic tumors
  • 1. Epidemiology
  • 2. Prevention, early detection, and screening
  • 3. Staging
  • 4. Histopathology and molecular pathology
  • 5. Oncogenic driver mutations
  • 6. First line therapy of advanced non-small cell lung cancer without activating EGFR mutation
  • 7. First line therapy of advanced non-small cell lung cancer with activating EGFR mutation
  • 8. Second line therapy of non-small cell lung cancer
  • 9. Adjuvant and neoadjuvant therapy of non-small cell lung cancer
  • 10. Advances in surgery of lung cancer
  • 11. Advances in radiotherapy of lung cancer
  • 12. Small cell lung cancer
  • 13. Mesothelioma
  • 14. Thymoma

 

Γράψτε μια αξιολόγηση

Σημείωση: η HTML δεν επεξεργάζεται!
Κακή Καλή